Joseph B. Domachowske

Infectious Disease

750 E Adams St
Syracuse, NY 13210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Preventing COVID-19 in at-risk populations: moving toward next-generation mRNA-1283 COVID-19 vaccine to address current challenges.

Preventing COVID-19 in at-risk populations: moving toward next-generation mRNA-1283 COVID-19 vaccine to address current challenges.

Journal: Expert review of vaccines

Published: February 26, 2026

Vaccine attitudes, practices, and literacy among New York State primary care providers and their office personnel.

Vaccine attitudes, practices, and literacy among New York State primary care providers and their office personnel.

Journal: Human vaccines & immunotherapeutics

Published: July 16, 2025

Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas.

Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas.

Journal: Vaccines

Published: July 15, 2025

Correction: Rapid diagnosis of acute pediatric respiratory infections with Point-of-Care and multiplex molecular testing.

Correction: Rapid diagnosis of acute pediatric respiratory infections with Point-of-Care and multiplex molecular testing.

Journal: Infection

Published: June 30, 2025

Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12-15 months: results of a phase II, controlled, randomized trial.

Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12-15 months: results of a phase II, controlled, randomized trial.

Journal: Vaccine

Published: June 05, 2025

Medically Attended Outpatient Parainfluenza Virus Infections in Young Children from a Single Site in Machala, Ecuador.

Medically Attended Outpatient Parainfluenza Virus Infections in Young Children from a Single Site in Machala, Ecuador.

Journal: International journal of environmental research and public health

Published: April 01, 2025

Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.

Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.

Journal: Expert review of anti-infective therapy

Published: March 20, 2025

Rapid diagnosis of acute pediatric respiratory infections with Point-of-Care and multiplex molecular testing.

Rapid diagnosis of acute pediatric respiratory infections with Point-of-Care and multiplex molecular testing.

Journal: Infection

Published: February 27, 2025

Clinical, Meteorological, and Air Quality Factors Associated with Ambulatory Pediatric Respiratory Syncytial Virus Infection in Machala, Ecuador, 2018-2023.

Clinical, Meteorological, and Air Quality Factors Associated with Ambulatory Pediatric Respiratory Syncytial Virus Infection in Machala, Ecuador, 2018-2023.

Journal: International journal of environmental research and public health

Published: October 23, 2024

Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study.

Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 06, 2024

Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.

Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.

Journal: The Pediatric infectious disease journal

Published: July 10, 2024

RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing.

RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing.

Journal: Pediatrics

Published: April 24, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026